Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TULIP: Lantus Early Initiation in T2D
NCT00174681Phase 4Completed
- Sponsor
- Sanofi
- Start
- Apr 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 6
01
Overview
A Phase 4 trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Apr 2003; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00174681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00174681.